Observations reveal enhanced LPS uptake in LPS-tolerant macrophage-like cells, indicating immune modulation through increased CD14 expression.
Lipopolysaccharide (LPS) tolerance can be recognized as a modulation of innate immune responses rather than merely a hyporesponsiveness to LPS, with CD14 being crucial for both LPS uptake and LPS signaling. In this study, we observed that LPS-tolerant mouse macrophage-like cells, in which LPS-induced TNF-α and IFN-β production was suppressed, exhibited a dramatic increase in surface CD14 expression. Also, we found that LPS uptake was enhanced in LPS-tolerant mouse macrophage-like cells, but not when treated with an anti-CD14 antibody. While previous studies have reported increased CD14 expression and enhanced LPS uptake in LPS-tolerant cells, our findings reveal that overexpressed CD14 in LPS-tolerant mouse macrophage-like cells is responsible for the enhanced LPS uptake in these cells.
No takes yet. Share an insight, caveat, or question.
Nishihara et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: